Events and Presentations

Dr Michael Oefelein will be presenting on behalf of Prokarium at the American Urology Association (AUA) Annual Meeting,...

Prokarium’s CEO, Ibraheem Mahmood, presented interim data at this year’s European Association of Urology conference in London.

Prokarium’s COO, Dara Henry, will be attending BIO-Europe Spring in Lisbon, Portugal, 23-25th March 2026.

Prokarium’s CSO, Livija Deban, will be presenting at NextGen Biomed 2026 in London, UK, 24-25th March 2026.

Prokarium’s CEO, Ibs Mahmood, will be presenting at the 41st Annual EAU Congress, London, UK, 13-16th March 2026. Presentation information:

Prokarium’s CSO, Livija Deban, will be attending the IO360° Summit in Boston, MA, 10-12th February 2026.

Prokarium’s CEO, Ibs Mahmood, CSO, Livija Deban, and COO, Dara Henry, will be attending the 44th Annual J.P. Morgan Healthcare Conference, San Francisco, California, 12-15 January 2026.

Prokarium to attend Tumour Models Summit London

Prokarium’s CSO, Livija Deban, and COO, Dara Henry, will attending the London Life Sciences Week, London, UK, 16-21 November 2025.

Prokarium’s CSO, Livija Deban, will be presenting at the ELRIG’s “Outside the norm: Engineering biology for drug discovery” UK Forum, Warwick, UK, 13 November 2025.

Prokarium’s COO, Dara Henry, will be attending BIO-Europe in Vienna, Austria, 11-12 November 2025.

Prokarium’s CSO, Livija Deban, will be presenting at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in Maryland, USA, 5-9 November 2025.

Prokarium’s COO, Dara Henry, will be speaking at TechBio UK in London, UK, 16 Ocober 2025.

Prokarium’s CEO, Kristen Albright, and COO, Dara Henry, will be attending the BIO International Convention 2025 in Boston, USA, 16-19 June 2025.

Kristen Albright, Prokarium’s CEO, will be presenting at the LSX World Congress event on 30th April in London.

Prokarium will be in Las Vegas between 26-29 April for AUA 2025.

Prokarium’s VP Research, Nicholas Glanville, is presenting a poster at the AACR Annual Meeting, Chicago, IL, 25-30 April 2025.

Prokarium’s CEO, Kristen Albright, is speaking at Executive Insights in Stockholm, Sweden, 10 April 2025.

Prokarium’s CEO, Kristen Albright, is speaking at BioTrinity in London, UK, 1-2 April 2025.

Prokarium’s CSO, Livija Deban, will be attending the 11th Annual IO360 Summit in Boston MA, USA, 24-26 March 2025.

Prokarium’s COO, Dara Henry, will be attending BIO-Europe Spring in Milan, Italy, 17-19 March 2025.

Prokarium’s CSO, Livija Deban, will be presenting at NextGen Biomed 2025, London, 12-14 March 2025.

Prokarium’s CSO, Livija Deban, will be presenting at the 9th Annual Microbiome Summit in Barcelona, Spain 28th-30th January 2025.

Prokarium’s CEO, Kristen Albright, and COO, Dara Henry, will be in San Francisco 12th-16th January for J.P. Morgan Healthcare Conference 2025.

Prokarium’s Chief Scientific Officer, Livija Deban, and VP of Research, Nick Glanville, are presenting at SITC 2024 in Houston 6th-10th November.

Prokarium’s CEO, Kristen Albright and COO, Dara Henry, to attend Bio-Europe 2024 in Stockholm November 4th-6th 2024.

Dara Henry, Prokarium’s COO, to attend BioJapan 2024 in Yokohama October 9th-11th 2024.

Dara Henry, Prokarium’s COO, to attend ESMO Congress 2024 in Barcelona September 13th-17th 2024.

Marc Biarnes Carrera, to present a poster at SEED 2024, in Atlanta, Georgia, 26th June 2024.

Kristen Albright, Prokarium’s CEO, to attend BIO International Convention in San Diego June 3rd 2024.

Prokarium’s CSO, Livija Deban, and Alex Sevko, Director, Translational Research, will be presenting at the 21st CIMT Annual Meeting. Poster No.108 on May 15th, 3:00 pm-5:30 pm.

Prokarium’s CEO, Kristen Albright, will attend Swiss Biotech Day in Basel on 22nd April.

Prokarium’s CSO, Livija Deban, will be speaking at the OECD – OCDE forum in Paris on 22nd April.

Dara Henry, Prokarium’s COO, will be attending BIO-Europe Spring conference in Barcelona on 18th – 20th March

Kristen Albright, Prokarium’s CEO, will be attending Cowen 44th Annual Health Care Conference, 4-6th March 2024, Boston, MA.

Kristen Albright, Prokarium’s CEO and Livija Deban, Prokarium’s CSO, will be attending 10th Annual IO360 Conference, 27-29th February 2024, New York.

Kristen Albright, Prokarium’s CEO, Dara Henry, Prokarium’s COO and Livija Deban, Prokarium’s CSO, will be attending J.P. Morgan 2024 Healthcare Conference, 8 – 11 January 2024, San Francisco.

Kristen Albright, Prokarium’s CEO, and Dara Henry, Prokarium’s COO, will be attending Jeffries 2023 London Healthcare Conference, 14 – 16 November 2023.

Kristen Albright, Prokarium’s CEO, will be presenting at the LSX Investival Showcase event on 13 November in London.

Dara Henry, Prokarium’s COO, will be attending Bio-Europe 2023 in Munich, from 6-8th November 2023.

Livija Deban, Prokarium’s CSO, and Alexandra Sevko, Director of Translational Research, will be presenting at the SITC event on 4th November in San Diego, CA.

Livija Deban, Prokarium’s CSO, and Alexandra Sevko, Director of Translational Research, will be presenting at the SITC event on 4th November in San Diego, CA.

Kristen Albright, Prokarium’s CEO, will be speaking at the BioVenture Nexus event on 5 October in Los Angeles, CA.

Kristen Albright, Prokarium’s CEO, will be presenting at the BioCentury-BayHelix East-West Summit on 3 October in Boston.

Livija Deban, Prokarium’s CSO, will be presenting at CICON23 Title: IO Prime: Restoring Immune Fitness with Oral Salmonella Typhi ZH9 to Unlock the Full Potential of Cancer Immunotherapies (Poster: P118) When: 21 September 2023

Kristen Albright, Prokarium’s CEO, will be attending the 23rd Annual Biotech in Europe Forum from 20-21 September 2023 in Basel.

Marc Biarnes Carrera, Prokarium’s Head, Discovery, Synthetic Biology, poster presentation at SynBioBetaTitle: A pipeline for the evolution and delivery of therapeutic cargo by SalmonellaWhen: May 23-25, 2023; Poster P005

Kristen Albright, Prokarium’s CEO, will share Prokarium’s story at Ginkgo Bioworks Annual Ferment conference in Boston.

Kristen Albright, Prokarium’s CEO, will be attending the 9th Annual LSX World Congress from 3-4 May 2023 in London.

Kristen Albright, Prokarium’s CEO, will be part of the Oncology Advanced Therapeutics Panel on March 2nd at the Annual European Life Science CEO Forum at SACHS.

Kristen Albright, Prokarium’s CEO, will be attending the BIO CEO & Investor Conference in New York February 6-9, 2023

Kristen Albright, Prokarium’s CEO, and Livija Deban, Prokarium’s CSO, will be attending the IO360° Conference in New York, February 7-10, 2023

Alexandra Sevko, Prokarium’s Director of Translational Research, will discuss “Urine as a Source for Biomarker Analysis” on February 27th at 11:10am. Alexandra will be also part of the panel “Implementing Patient-Centric Biomarkers In Clinical Trials” on February 28th at 3:40pm.

Kristen Albright, Prokarium’s CEO, will be attending the Jefferies London Healthcare Conference November 15-17, 2022

Livija Deban, Prokarium’s CEO, will be presenting at SITC 2022.Title: Overcoming the suppressive microenvironment with a live bacterial immunotherapyWhen/Where: November 11th, 2022; Poster Session

Alexandra Sevko, Prokarium’s Director of Translational Research will be presenting at the Tumour Microenvironment ConferenceTitle: Salmonella Typhi ZH9 as a novel microbial immunotherapy for bladder cancerWhen/Where: November 1st, 2.30pm CET; Emerging therapeutics opportunity in IO session

Martina Lubrano di Ricco, Prokarium’s Business Development Manager, is attending Bio-Europe 2022 in Germany

Marc Biarnes Carrera, Prokarium’s Principal Scientist, will be part of a panel discussing models to enable engineering biology on October 13th 2022 at 2.45pm

Livija Deban, Prokarium’s CSO, will be chairing the Translational and Preclinical Development session at Immuno UK on September 30, 8.50am

Nicholas Glanville, Prokarium’s Director of Preclinical Research, and Alexandra Sevko, Prokarium’s Director of Translational Research will present at CICONTitle: Overcoming the suppressive tumour microenvironment with a live bacterial immunotherapyWhen/Where: September 29, 12-2pm ET; Poster Session A

Kristen Albright, Prokarium’s CEO, to present at SACHS forum

Kristen Albright, Prokarium’s CEO, will be presenting on May 11 at 2.30pm at the LSX Conference in London